RGT 2.90% 35.5¢ argent biopharma limited

Ann: CIMETRA PATENT SUBMITTED TO EUROPEAN IP OFFICE, page-17

  1. 1,881 Posts.
    lightbulb Created with Sketch. 963
    This is yet another non-event announcement. This is a ‘patent’ pending product with little profit generating potential for years.... if ever! This is simply the same pig rolled out in another dress with different coloured lipstick.

    BOD is clearly getting desperate now, looking for saleable angle to suck more investors in to keep this leaky boat afloat.

    A few more worthless announcements like this one and the SP will soon be nil! The BOD thinks they have sufficient funding to support ongoing trials, fund patents and get the Mythical Malta complex operating while income generated struggles to pay their exorbitant wages. Good luck investors……………… you’ll need buckets loads of it!
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.